1.	A Clinical Study of PHY906 as a Modulator of CPT-11 in Patients With Metastatic Colorectal Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 0706002781, ACS IRG 58-012-49, NCT00730158
2.	Effects of Two Doses of MPX Capsules on Rising Prostate-specific Antigen Levels in Men Following Initial Therapy for Prostate Cancer Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J1161, NCT01317199
3.	Saw Palmetto: Symptom Management for Men During Radiation Therapy Phase: Phase II, Phase I Type: Supportive care Status: Active Age: 21 and over Sponsor: Other Protocol IDs: Application ID 213, NCT01585246
4.	Safety and Efficacy of Doses of Ingenol Mebutate Once Daily for Two or Three Consecutive Days in Subjects With Actinic Keratosis Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: LP0105-1012, NCT01820260
5.	Boswellia serrata and Standard Treatment or Standard Treatment Alone in Treating Patients Who Have Undergone Surgery and Radiation Therapy for Newly Diagnosed or Recurrent High-Grade Glioma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: CASE-CCF-7348, CCF-7348, NCT00243022, CASE1304200
6.	Use of Organic Germanium or Placebo for the Prevention of Radiation Induced Fatigue Phase: Phase II Type: Supportive care Status: Active Age: 18 and over Sponsor: Other Protocol IDs: Germanium, NCT00651417
7.	Herbal Therapy for Treatment of Recurrent Prostate Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 4P-07-3, NCT00669656
8.	Study of Polyphenon E in Men With High-grade Prostatic Intraepithelial Neoplasia Phase: Phase II Type: Prevention Status: Active Age: 30 to 80 Sponsor: NCI, Other Protocol IDs: MCC-15008, R01 CA12060-01A1, NCT00596011
9.	Safety and Exploratory Efficacy of Kanglaite Injection in Pancreatic Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: KLT-PANC-001, NCT00733850
10.	Green Tea and Reduction of Breast Cancer Risk Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 50 to 64 Sponsor: NCI, Other Protocol IDs: 0806M36121, NCT00917735
11.	Study to Evaluate the Effect of Sulforaphane in Broccoli Sprout Extract on Breast Tissue Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: J0822, NCT00982319
12.	Safety and Efficacy of Kanglaite Gelcaps in Prostate Cancer Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Pharmaceutical / Industry Protocol IDs: C10-069, NCT01483586
13.	Green Tea Catechin Extract in Preventing Polyps in Patients at High-Risk for Recurrent Colon Polyps Phase: Phase II Type: Biomarker/Laboratory analysis, Prevention Status: Active Age: 40 and over Sponsor: NCI Protocol IDs: MAYO-MC084C, MC084C, R01-CA-132991
14.	Study to Assess the Activity of Nexrutine® in Prostate Cancer Patients Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: HSC20100308H, NCT01705652
15.	Phase I Chemoprevention Trial With Green Tea Polyphenon E and Erlotinib in Patients With Premalignant Lesions of the Head and Neck Phase: Phase I Type: Prevention Status: Active Age: 18 and over Sponsor: Other Protocol IDs: WCI1549-08, NCT01116336
16.	Study Investigating the Ability of Plant Exosomes to Deliver Curcumin to Normal and Colon Cancer Tissue Phase: Phase I Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 20 and over Sponsor: Other Protocol IDs: BCC-GI-10 Curcumin, NCT01294072
17.	Curcumin in Treating Patients With Familial Adenomatous Polyposis Phase: No phase specified Type: Treatment Status: Active Age: 18 to 85 Sponsor: NCI Protocol IDs: NCI-2013-00536, 00011821, R01CA134620, NCT00641147
18.	The Effect of Berries on Lung Cancer Tumors Phase: No phase specified Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 08.0040, BCC-LUN-07-002, NCT00681512
19.	Curcumin Biomarker Trial in Head and Neck Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 to 90 Sponsor: NCI, Other Protocol IDs: H08-081, 1R21CA137545-01A2, FWCC, NCT01160302
20.	Cruciferous Vegetable Intake and Histone Status in Screening Colonoscopy Patients Phase: No phase specified Type: Biomarker/Laboratory analysis, Prevention, Screening Status: Active Age: 50 to 75 Sponsor: NCI, Other Protocol IDs: P01 CA090890, NCT01344330
21.	Green Tea Anticancer Mechanisms in Smokers Phase: No phase specified Type: Prevention Status: Active Age: 23 to 40 Sponsor: Other Protocol IDs: 2007C0109, NCT01162642
22.	A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ Phase: No phase specified Type: Supportive care, Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: EH0524BlackCohosh, NCT01628536
23.	Ingenol Mebutate Compared to Cryotherapy for the Treatment of Skin Lesions Phase: No phase specified Type: Treatment Status: Active Age: 18 to 89 Sponsor: Other Protocol IDs: STU68227, NCT01735942
24.	Broccoli Sprout Extract in Treating Patients With Estrogen Receptor-Positive Breast Cancer Phase: No phase specified Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 21 and over Sponsor: NCI, Other Protocol IDs: I 211911, NCI-2012-01770, K07CA148888, NCT01753908